FDA Warns of Serious Slowing of Heart Rate with Hepatitis C Drugs and Amiodarone
May 30th 2015The FDA approved label warning changes for two Gilead Sciences hepatitis C drugs after one person died and nine others had serious reactions when the drugs were coadministered with amiodarone, a drug used to treat irregular heartbeat.
Read More
Serious Liver Disease Rates Higher Among Coinfected Patients
June 19th 2014Study results show hepatic decompensation is more common in people who have both HIV and hepatitis C virus (HCV) compared to those infected only with HCV, an indication that early HCV treatment among coinfected patients is needed.
Read More